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Abstract
Estrogen disrupting chemicals are environmental compounds which mimic, antagonize or interfere in the action of 
physiological estrogens. They occur naturally (plant phytoestrogens) but the majority are man-made compounds, 
which, through their use in agricultural, industrial and consumer products, have become widely present in human 
tissues including breast tissue. Since exposure to estrogen is a risk factor for breast cancer, estrogen disrupting 
chemicals may also contribute to breast cancer development. This review discusses evidence implicating estrogen 
disrupting chemicals in increasing migratory and invasive activity of breast epithelial cells, in epithelial-to-
mesenchymal transition, and in growth of breast tumours at metastatic sites as well as the primary site. Mechanisms 
may be through the ability of such chemicals to bind to estrogen receptors, but unlike for proliferation, effects on cell 
migration and invasion are not limited to estrogen receptor-mediated mechanisms. Furthermore, whilst effects on 
proliferation can be measured within hours/days of adding an estrogen disrupting chemical to estrogen-responsive 
breast cancer cells, effects on cell migration occur after longer times (weeks). Most studies have focused on 
individual chemicals, but there is now a need to consider the environmentally relevant effects of long-term, low-
dose exposure to complex mixtures of estrogen disrupting chemicals on mechanisms of metastasis.
Keywords: Aluminium, breast cancer, estrogen disrupting chemicals, invasion, metastasis, migration, paraben, 
personal care products, UV filter.
INTRODUCTION
Estrogen disrupting chemicals are exogenous environmental compounds that can interfere in the action 
of endogenous estrogens. Through their ability to bind to estrogen receptors, they may be able to mimic or 
antagonize the cellular actions of physiological estrogens[1]. They may also influence synthesis, transport, 
metabolism and clearance of physiological estrogens[1]. Some are found naturally in plants (phytoestrogens) 
or fungi (mycoestrogens), but the majority are man-made compounds to which the human population is 
widely exposed through their use in agricultural, industrial and consumer products[1]. Such compounds 
are used as components of pesticides and herbicides in agricultural, urban and domestic environments. 
They are widely used in industrial applications and occur as byproducts of combustion from vehicles, 
aircraft and ships. These compounds are found as components in plastics, with applications from building 
materials to food/water containers, in detergents used for cleaning in industrial and domestic settings, and 
as flame retardants in soft furnishings. A range of components added to personal care products are also 
now known to possess estrogen disrupting activity[1]. Some more specific examples are shown in Table 1. 
Intake to the human body may be by the oral route (food/water) or inhalation (air pollution) or dermal 
absorption (products applied to skin or present in the air). So ubiquitous are the many estrogen disrupting 
chemicals in modern life that exposure is almost never from a single source but rather from multiple 
sources reflecting not only occupational exposures but also personal lifestyle choices.
Since exposure to estrogens is an established risk factor for breast cancer[2], it is thought that estrogen 
disrupting chemicals may also contribute to breast cancer development if they are present in human 
breast tissue at sufficient concentrations[1]. Development of cancer is a lengthy and complex process, that 
originates from a loss of growth control, and culminates in metastatic tumour spread. Both genetic and 
environmental influences interact to enable the associated hallmarks of cancer to develop[3]. The hallmark 
of sustained cell proliferation in breast cancer is well established as involving estrogens[4] and probably also 
estrogen disrupting chemicals[5]. Since metabolism of some endogenous estrogens gives rise to genotoxic 
compounds[6] and since some estrogen disrupting chemicals are also genotoxic[1], a role has been recognized 
in generating genomic instability which is an underlying enabling characteristic of cancer[3]. However, 
the role of endogenous and exogenous estrogens in contributing to the processes of metastatic tumour 
spread are less well established. This is especially important in the context of breast cancer where the main 
cause of mortality arises from growth of metastatic tumours[2,7]. This review will discuss current evidence 
suggesting that endogenous and exogenous estrogens can contribute to increasing migratory and invasive 
activity of breast epithelial cells which are hallmarks of cancer required for the metastatic process[3].
ENDOGENOUS ESTROGENS AND METASTASIS
Cellular actions of estrogens are mediated through binding to specific receptor proteins[8]. There are two 
types of nuclear estrogen receptors, estrogen receptor a (ERa) and estrogen receptor b (ERb) which exist as 
multiple isoforms and which function as ligand-activated transcription factors to influence patterns of gene 
expression[8]. Final outcomes are dependent on the affinity of ligand binding to receptor, the concentrations 
of receptors in the target cells and the presence of co-acting factors/transcription factors[8]. In addition, 
estrogenic ligands can also act through binding to membrane-associated molecules such as the G-protein-
coupled estrogen receptors[8,9]. 
Metastasis involves a complex series of events whereby the malignant cells break away from the primary 
tumour, invade through local tissue, infiltrate circulatory vessels (blood and/or lymph) and at distant 
sites exit the vessels to from new foci of cancer cell growths (colonization)[7]. Endogenous estrogens 
can inf luence all these processes including immune evasion and the angiogenesis needed for effective 
metastatic colonization[10]. In their capacity to regulate growth of estrogen-responsive human breast cancer 
cells[2,4], estrogens can inf luence metastatic tumour growth at both the primary and secondary sites[2]. 
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However, endogenous estrogens are also now known to be able to influence cell motility, cell migration and 
invasive behavior of human breast cancer cells through altering expression of proteins and transcription 
factors key to the process of epithelial to mesenchymal transition (EMT). EMT is a process in which 
the epithelial cells lose their polarity and strong cell-cell adhesion properties in order to assume a more 
mesenchymal phenotype lacking the polarization and the strong cell-cell interactions. The cell adhesion 
junctions of epithelial cells are reliant on high levels of E-cadherin which is a transmembrane protein 
linked to the cytoskeleton by a- and b-catenin, and EMT is typically associated with reduction in levels 
of these adhesion proteins. It is also associated with altered levels of transcription factors (such as slug 
and snail) which control expression of the adhesion proteins[7]. This allows the cells to break away from 
neighbouring cells and to become generally more motile. Human breast cancer cell lines which possess 
ERa (ERa+) tend to be less invasive, less metastatic and possess higher levels of E-cadherin than those 
which lack ERa (ERa-)[11]. Knockdown of ERa in the ERa+ cell lines has been shown to result in decreased 
E-cadherin and increased slug expression[12]. Conversely, transfected overexpression of ERa in the ERa- cell 
lines has been shown to enable estrogen-mediated increase in E-cadherin and decrease in slug[12]. In the 
ERa+ MCF-7 human breast cancer cell line, estradiol can increase EMT whilst the antiestrogen tamoxifen 
can reduce EMT[13] suggesting that the mechanism is ER-dependent. However, there appear to be multiple 
molecular mechanisms involving not only genomic alterations to levels of E-cadherin and associated 
transcription factors such as slug[12] but also non-genomic alterations via c-src and phosphorylation of focal 
adhesion kinase[14,15]. 
In order to facilitate invasion through local tissue, the cells need also to secrete greater levels of 
extracellular proteases which aid in the digestion of the surrounding extracellular matrix (ECM). Some of 
the extracellular proteases identified specifically in human breast cancer cells are matrix metalloproteinases 
(MMPs)[16,17] and cathepsin D[18]. It is notable that one of the first estrogen-regulated genes to be identified 
was cathepsin D[19] and studies now also show effects of estrogen on expression of MMPs[16]. These studies 
attest to the role of estrogen in altering proteases which can degrade the ECM.
Estrogens are also known to play a role in the processes of angiogenesis[10,20]. Vascular endothelial growth 
factor (VEGF) is a key angiogenesis promoting factor and the VEGF gene has been shown to possess 
functional estrogen response elements indicating it is an estrogen-responsive gene[21]. Estrogen treatment 
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Table 1. Estrogen disrupting chemicals: example compounds, uses in the environment, and sources of human exposure 
DDT: dichlorodiphenyltrichloroethane
Use in the environment Example compounds Source of human exposure
Plant phytoestrogens Genistein, daidzein Edible plant material (diet, dietary supplements)
Pharmaceuticals Ethinylestradiol Contraceptive pill, hormone replacement therapy, cosmetics
Pesticides DDT, lindane, pyrethroids Pesticide products, animal fat (diet)
Herbicides Glyphosate Garden weedkillers
Industrial Polychlorinated biphenyls Animal fat (diet)
By-product of incineration Polychlorinated dioxins Inhaled; animal fat in diet
Flame retardant Polybrominated organics Domestic environment from use on soft furnishings
Plastics, epoxy resins Bisphenol A Storage of food and beverages (diet); domestic environment
Plastics Phthalate esters Domestic consumer products
Detergent Alkyl phenols Domestic environment
Preservative Parabens Personal care products, food, pharmaceuticals
Antiperspirant Aluminium chlorohydrate Underarm antiperspirants
Antimicrobial Triclosan Personal care products, domestic consumer products
Absorb ultraviolet light Benzophenones Suncare products, other cosmetics, clothing
Fragrance Butylphenylmethylpropional, 
benzyl salicylate, musks
Personal care products, domestic consumer products
Conditioning/spreading agent Cyclic volatile methylsiloxanes Personal care products
Cigarettes Cadmium Cigarette smoking
has also been reported to increase intra-tumoural angiogenesis[22] and VEGF levels[23] in mouse models of 
breast cancer. 
ESTROGEN DISRUPTING CHEMICALS AND METASTASIS
On the basis that endogenous estrogens can influence processes necessary for metastasis, it would seem 
plausible that estrogen disrupting chemicals will also contribute if they can enter breast tissue and target 
metastatic tissues at sufficient concentrations. Whilst endogenous estrogens are subject to physiological 
regulation in terms of both concentration and timing, it is noteworthy that the estrogen disrupting 
chemicals are not regulated in this manner. The presence of estrogen disrupting chemicals in the body 
will follow rather intake from environmental exposures balanced by rates of elimination and ability 
of individual chemicals to bioaccumulate. Many estrogen disrupting chemicals tend to be lipophilic 
accumulating in body fat over the years such that body burdens increase with age[1]. In this context it may 
be significant that 80% of breast cancers occur in women over the age of 50[24] at a time when endogenous 
estrogens are reduced following menopause but exogenous estrogen disrupting chemical body burdens 
would be continuing to increase.
Estrogen disrupting chemicals and metastatic colonisation
Metastasis of breast cancer cells begins with local spread within the breast and to the underarm lymph 
nodes. The pattern of more distant dissemination is less predictable with preferred sites of colonization 
being brain, bone, lungs and liver[7]. Stephen Paget’s original “seed and soil” hypothesis proposed that 
preferred sites of metastasis would reflect a favourable organ microenvironment in which the metastatic 
breast cancer cells could grow[25]. His hypothesis was based on the tenet that “when a plant goes to seed, its 
seeds are carried in all directions, but they can only live and grow if they fall on congenial soil”. For breast 
cancer cells, one important favourable element for cell growth would be an “estrogenic” environment and 
it is in this context that estrogen disrupting chemicals may influence sites of metastatic spread. Estrogen 
disrupting chemicals have been widely measured in human populations across the globe in body fluids 
such as blood and urine and in various body tissues[1]. With such widespread contamination of the human 
body, it is becoming accepted that there are ramifications for human health including effects on male 
and female reproduction and on cancers in reproductive tissues[1]. The presence of estrogen disrupting 
chemicals across many body tissues could act to change a previously non-favourable location into a 
favourable environment for colonization and growth of human breast cancer cells into metastatic tumours. 
Evidence for effects of estrogen disrupting chemicals on the metastatic process
There is now mounting evidence for effects of the parabens, ultraviolet (UV) filters, aluminium salts, 
triclosan, phthalates, bisphenol A (BPA), dioxins and phytoestrogens in the processes of EMT, motility, 
migration and invasion, and relevant studies of breast cells are discussed below. Most studies to date have 
been based in vitro but there are some animal models which demonstrate measurable effects also in vivo. 
Many of the mechanisms may involve mimicking the action of endogenous estrogens through the ability 
of these estrogen disrupting chemicals to bind to estrogen receptors, but unlike for proliferation, the effects 
on migration and invasion do not seem to be limited to ER-mediated mechanisms. Furthermore, whilst 
effects on proliferation can be measured within hours/days of adding an estrogen disrupting chemical to 
estrogen-responsive breast cells, effects on migration tend to occur after a longer time frame of weeks. The 
reasons why the time taken is longer remain unknown but would be important to determine in future 
research. 
Parabens
The alkyl esters of p-hydroxybenzoic acid (parabens) are added as preservatives to personal care 
products, pharmaceuticals and foods[1]. Of the five commonly used esters (methylparaben, ethylparaben, 
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n-propylparaben, n-butylparaben and isobutylparaben) 99% of the human breast tissues were found to 
contain at least one of the esters, and 60% contained all five esters[26]. Although the parabens bind more 
weakly to estrogen receptors than do the endogenous estrogens, their efficacy is not weak provided 
sufficient concentration is present[27]. It is therefore noteworthy that the concentrations of parabens 
measurable to human breast tissues are considerably higher (in the micromolar range)[26] than the levels of 
endogenous 17b-estradiol (in the nanomolar range)[2,28]. Previous work has demonstrated that parabens can 
increase proliferation of estrogen-responsive human breast cancer cells in cell culture at concentrations 
measurable in some human breast tissue samples[29] through estrogen receptor-mediated mechanisms[27]. 
However, parabens have now been found to also increase migratory and invasive activity of human breast 
cancer cells in culture[30]. Migratory activity was measured using scratch assays, time-lapse microscopy 
and xCELLigence technology[30]. Invasive activity was measured using matrix degradation assays and 
invasion through matrigel on the xCELLigence system[30]. Unlike the proliferative effects which were 
measurable within days of addition of the parabens[27,29], the increased migratory and invasive properties 
only developed in the cells after long-term exposure (20 weeks)[30]. Western immunoblotting showed an 
associated downregulation of E-cadherin and b-catenin in the long-term paraben-exposed cells, which 
could be consistent with a mechanism involving EMT[30].
One technology which has been particularly useful in determining adhesion, migration and invasion 
of breast cells following exposure to estrogen disrupting chemicals has been the ACEA BioSciences 
xCELLigence technology, and the increased cell migration following long-term exposure of MCF-7 human 
breast cancer cells to paraben which was measured using this technology is shown in Figure 1A. This 
technology works on the basis of a modified Boyden chamber in which two chambers are separated by a 
membrane. Migration of cells through the membrane on the base of the upper chamber can be monitored 
in real time at any pre-determined time interval as the cells move onto the undersurface of this membrane 
located at the top of the lower chamber. The CIM-plate-16 contains 16 wells which can be monitored 
independently but simultaneously to measure cell migration/invasion in real time through 8 mm pores 
in the membrane onto gold electrodes on the underside of the membrane using the ACEA BioSciences 
xCELLigence analyser system. Cell movement onto the gold electrodes is measured as electrical impedance 
(cell index). Collated traces of cell index are shown in Figure 1A for cell migration through uncoated 
membranes following 20 weeks of prior treatment with or without 5 × 10-4 M methylparaben or 10-5 M 
n-butylparaben (conditions as published in reference 30).
UV filters
Chemicals which can absorb UV light (UVA and/or UVB) are added to consumer products either to 
protect the skin of the user from UV damage (sunscreen products) or to protect the product itself from UV 
damage during storage[31]. They are also used in textiles marketed as UV protective clothing[32]. Widespread 
use of benzophenone-3 (BP-3), octylmethoxycinnamate (OMC) and 4-methylbenzilidenecamphor (4-MBC) 
has led to their detection in environmental water and soil samples[33] and they have been recently also 
measured as present in human breast tissues[34]. One or more of these UV filters were quantifiable in 84% of 
the breast tissue samples and in at least one breast region of 95% of the women[34]. BP-3, OMC and 4-MBC 
all possess estrogenic activity in reporter gene assays in estrogen-responsive MCF-7 human breast cancer 
cells[31,35]. Long-term exposure (23 weeks) to any one of these three compounds has now also been found to 
increase migratory activity in MCF-7 cells using scratch assays, time-lapse microscopy and xCELLigence 
technology, and to increase invasion through matrigel as measured using xCELLigence technology[35]. 
The increased cell migration following long-term treatment (23 weeks) of the MCF-7 cells with or without 
10-5 M of BP-3 or OMC is shown in Figure 1B using xCELLigence technology (conditions as published in 
reference 35). However, increased motility of estrogen‐unresponsive MDA‐MB‐231 human breast cancer 
cells was also observed after long-term exposure to each of the three compounds, implying the increased 
migratory activity was not confined to estrogen responsive cells[35]. Furthermore, molecular mechanisms 
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differed between compounds and cell lines, with a noted loss of b-catenin only after long-term exposure to 
OMC in the MCF-7 cells and an increase in MMP-2 after long-term exposure to OMC and 4-MBC in the 
MDA-MB-231 cells[35].
Aluminium-based antiperspirant salts
Aluminium-based salts are used as antiperspirant in underarm cosmetics and dermal absorption of 
aluminium from this use has been implicated in the development of breast cancer[36]. Aluminium has 
been measured in human breast tissue[37] and breast cyst f luid[38] at higher levels than in blood, and in 
nipple aspirate f luid at higher levels in samples taken from women with than without breast cancer[39]. 
Aluminium, as well as several other metal ions, is a metalloestrogen[40] and in the form of the antiperspirant 
salts aluminium chloride or aluminium chlorohydrate it can displace radiolabeled 17b-estradiol from 
estrogen receptors and regulate estrogen-responsive gene expression[41]. However, aluminium has also been 
shown to increase migratory and invasive activity of human breast cancer cells, although since effects were 
found not only in estrogen-responsive MCF-7[42] but also estrogen-unresponsive MDA-MB-231[43] cells, 
estrogen-independent mechanisms of action must also exist. The increased cell migration following long-
term (32 weeks) treatment of MCF-7 cells with or without 10-4 M aluminium chlorohydrate are illustrated in 
Figure 1C using xCELLigence technology (conditions as published in reference 42). More recent animal model 
research has shown that non-transformed murine mammary gland (NMuMG) epithelial cells exposed 
to aluminium chloride in vitro were transformed as judged by soft agar assay, and then when injected 
into three mouse strains with increasing immunodeficiency formed tumours and metastasised in vivo[44]. 
Untreated cells formed tumours and metastasized to a limited extent in the highly immunodeficient and 
natural killer (NK) cell deficient NSG mouse strain but not in the less permissive and NK cell competent 
NOD SKID strain or nude strains. In contrast, NMuMG cells transformed in vitro by the aluminium 
chloride formed large tumours and metastasized in all three mouse models[44].
Figure 1. Increases in migration of MCF-7 human breast cancer cells following prior long-term exposure to several estrogen 
disrupting chemicals contained in personal care products. Cell migration was measured in real-time as electrical impedance (cell 
index) using xCELLigence technology with uncoated CIM-16 plates. Prior to the assay, cells had been grown. A: for 20 weeks with 
no addition, 5 × 10–4 M methylparaben or 10–5 M n-butylparaben; B: for 23 weeks with no addition, 10–8 M 17b-estradiol, 10-5 M 
octylmethoxycinnamate or 10-5 M benzophenone-3; C: for 32 weeks with or without 10-4 M aluminium chlorohydrate; D: for 9 weeks 
with or without 10-7 M triclosan. Conditions were as published for the parabens[30], UV filters[35], and aluminium chlorohydrate[42]. 
Data for triclosan are unpublished personal results. UV: ultraviolet 
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Triclosan
Triclosan [5-chloro-2-(2,4-dichlorophenoxy)phenol] is a chlorinated aromatic compound which is added 
as a broadspectrum antimicrobial agent to consumer goods. It was first used as a hospital scrub but is now 
added widely to personal care products and homeware products[45]. It possesses estrogenic activity[46] and 
has been detected in human milk[45] implying its presence in the human breast. It can increase proliferation 
of estrogen-responsive human breast cancer cells[45]. More recently, exposure of MCF-7 human breast 
cancer cells to triclosan has been shown to increase migration and development of EMT associated with 
downregulation of E-cadherin and upregulation of N-cadherin, snail and slug[47]. The increased cell 
migration observed in our laboratory following long-term (9 weeks) exposure of MCF-7 cells to 10-7 M 
triclosan is shown in Figure 1D using xCELLigence technology (personal unpublished data).
Phthalates
Esters of phthalic acid (phthalates) are used as plasticisers in the manufacture of plastics. However, in 
addition to plastic goods, they are also found in many personal care products, adhesives, paints, air 
fresheners, food products, pharmaceuticals and textiles[1]. Many of the esters are listed by the Organisation 
for Economic Cooperation and Development (OECD) as high production volume chemicals[48], with some 
of the most used being diethylphthalate (DEP), dibutylphthalate (DBP), benzylbutylphthalate (BBP) and di-
(2-ethylhexyl)phthalate (DEHP). Metabolites of these esters are widely detected in human urine samples of 
the US population[49] and can be measured in human milk[50] implying their presence in the human breast. 
Many of these widely used esters and their metabolites possess estrogenic activity and can increase growth 
of estrogen-responsive human breast cancer cells[51,52]. Using a stem cell-derived human breast epithelial 
cell line R2d, DBP and BBP were found to induce EMT through an ER-mediated increase in mesenchymal 
markers and decrease in epithelial markers[53]. Furthermore, BBP has been reported to increase growth of 
tumours and lung-derived metastases in an in vivo mouse xenograft model using breast cancer stem cells. 
The mechanism was linked to an arylhydrocarbon receptor-mediated increase in sphingosine-1-phosphate 
receptor 3 (S1PR3) signaling since downregulation of this pathway reduced both the tumour growth and 
the lung metastasis but the role of estrogen in this remains unknown[54].
Bisphenol A
BPA is used in the manufacture of polycarbonate plastics and epoxy resins which are found ubiquitously 
in building materials and consumer products[55]. It is used to line food storage containers and water 
bottles from which it can leach out when heated[56]. It is listed by the OECD as a high production volume 
chemical[48]. A large literature links BPA to adverse health effects in animals and humans[55], and it is 
measurable in human body tissues including breast milk[57] which implies its presence in the human 
breast. Through its estrogenic activity, it is known to stimulate the proliferation of estrogen-responsive 
human breast cancer cells[56]. Animal models have revealed that prenatal exposure can enhance breast 
carcinogenesis in the chemically induced DMBA-mouse model[58] and alone can also cause disruption 
to the mouse mammary tissue increasing susceptibility to breast cancer[59]. However, chronic exposure 
to BPA in drinking water during adulthood was also shown to increase tumour burden and incidence 
of metastasis in a transgenic mouse model that spontaneously develops tumors through overexpression 
of erbB2[60]. More recent in vitro experiments with human breast cancer cells are beginning to suggest that 
BPA may increase cell migration and invasion. Exposure of SkBr3 human breast cancer cells to BPA (10-8 M) 
increased cell motility and downregulated the transcription factor FOXA1[61]. FOXA1 repression is thought to 
be characteristic of EMT because it is an activator of the E-cadherin gene[62]. Exposure of the human breast 
cancer cell lines MDA-MB-231 and BT-549 led to increased invasiveness with an associated increased 
expression of MMP-2 and MMP-9[63]. 
Dioxins
Polychlorinated dibenzodioxins (PCDDs) (dioxins) are highly toxic, bioaccumulative environmental 
pollutants generated as byproducts of combustion[64]. They are carried by air, washed off the land by 
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rainwater into rivers and lakes and then pass up the food chain dissolved in animal fat. They are measured 
ubiquitously in human tissues[64]. There are 75 congeners of which the most toxic is 2,3,7,8-tetrachlorodi
benzodioxin (TCDD)[64] and has been shown to exert molecular actions both through ER-mediated and 
AhR-mediated mechanisms[65]. Gene targets of the AhR include activation of slug and some MMPs[66]. In 
the ER+, AhR+ MCF-7 human breast cancer cells, TCDD has been found to downregulate E-cadherin and 
reduce cell-cell contacts in a JNK-dependent mechanism[67]. However, antiestrogenic actions of TCDD have 
been repeatedly reported over the years[65], and so it is noteworthy that TCDD has been reported to inhibit 
mammary tumour metastasis in vivo[68,69].
Phytoestrogens
Phytoestrogens are found in over 300 plant species and can be ingested by humans through consumption 
of plant material either in diet or as dietary supplements[70]. Flavonoids include genistein and daidzein 
found in soybeans and other legumes, coumestans in clover and young sprouting legumes, prenylflavonoids 
in hops. The most prevalent non flavonoids are lignans in cereals, fruits and vegetables. Although many 
purified phytoestrogens display estrogenic activity in vitro, the estrogenic actions on cell proliferation are 
concentration-dependent with only the lower doses increasing proliferation of estrogen-responsive human 
breast cancer cells, whilst higher doses inhibit[71], and many phytoestrogen-containing plant products are 
considered to have anti-tumour activity[70]. It is interesting therefore that emerging data seem to suggest 
that several phytoestrogens can act to reduce breast cancer cell migration and invasion including lignans[72], 
soy-derived daidzein[73], and formononetin[74]. Triclosan-induced EMT can be reversed by kaempferol[47]. 
However, one mouse model of breast cancer has shown that consumption of soy isof lavones increased 
growth of metastatic tumours in bone and lung[75].
THE ISSUE OF LOW-DOSE MIXTURES
The studies discussed above provide evidence that some individual estrogen disrupting chemicals can 
inf luence components of EMT and processes of migration and invasion in human breast cancer cells. 
However, since many hundreds of estrogen disrupting chemicals have now been measured in the human 
breast[1], the environmental reality is that, in today’s world, human breast cells in vivo are not exposed 
to single chemicals but to complex mixtures of pollutant chemicals. This is especially poignant in view 
of many estrogen disrupting chemicals being lipophilic and the human breast being a fatty organ. It is 
also highly relevant in the context of the many non-monotonic responses which have been reported for 
environmental endocrine disrupting chemicals in general, often with stronger responses at the relatively 
lower doses tested[76]. There are therefore outstanding questions as to the effects of exposure to complex 
mixtures of estrogen disrupting chemicals where each is present at low dose. For proliferation, it has been 
shown that mixtures of such chemicals can increase cell proliferation where the same concentrations of 
the estrogen disrupting chemicals individually do not, in what has now been nicknamed “the something 
from nothing” effect[77]. Even mixtures of the different esters of parabens can add together to give increased 
cell proliferation[29]. This is relevant environmentally where human breast tissue samples were found to 
contain differing levels of the individual paraben esters[26] and implies that the same outcomes can arise 
from different mixtures of estrogen disrupting chemicals[29]. Clearly in ER-mediated mechanisms, such as 
in increasing cell proliferation, each chemical will act according to its relative estrogen receptor binding 
affinity but low doses of different chemicals can add together until a maximum proliferative signal is 
achieved. As yet, there seems to be no published information as to whether the same effect of mixtures can 
be achieved on development of EMT or on increasing cell migration/invasion. Furthermore, since these 
studies are technically long and labour-intensive, the range of concentrations are often lacking in order to 
determine the extent to which non-monotonic responses may be occurring.
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CONCLUSIONS
It can be concluded that there is mounting evidence for a role of estrogen disrupting chemicals in 
contributing to the processes of metastatic tumour spread and this is summarized in Figure 2. Estrogen 
disrupting chemicals may contribute to loss of cell-cell adhesion, development of EMT and increased 
secretion of ECM-degrading proteases leading to increased cell motility, migration and invasion. However, 
estrogen disrupting chemicals are also likely to play a role in creating a favourable microenvironment for 
colonization and growth of metastatic tumours at distant sites. Unpredictable awakening from dormancy[7] 
could result from altered environmental exposures or indeed sudden release of estrogen disrupting 
chemicals from fat stores such as at times of weight loss. It is well established that estrogen disrupting 
chemicals are passed from mother to child in breast milk as they are mobilized with the fat in the milk[78]. 
Such detoxification of the the mother’s breast may provide an alternative explanation for the protective 
effect of breast feeding on incidence of breast cancer[79]. Likewise, release of estrogen disrupting chemicals 
from storage could change the microenvironment for “dormant niches”[7] causing renewed proliferation.
Research is now needed to answer outstanding questions concerning the effects of long-term exposure 
to low doses of chemicals and the effects of complex mixtures of chemicals[80]. Since estrogen disrupting 
chemicals are widely measurable in human tissues and some can bioaccumulate with age, then it follows 
that breast cells are exposed long term which requires long term cell culture modelling for further 
understanding. This is especially poignant in the acquisition of increased migratory and invasive 
properties described above which generally took weeks rather than days to develop. The effects of mixtures 
of chemicals each at low dose will be more difficult to resolve because personal lifestyle choices will 
inevitably result in differing chemical contents between individuals. Furthermore, due to the additive and 
complementary mechanisms of estrogen disrupting chemicals[81], different mixtures may have the same 
outcomes which makes tracing individual culprit chemicals impossible. However, if specific environmental 
exposures can be uncovered, then avoidance would be a good strategy for prevention. In 2001, I proposed 
a hypothesis that regular application of constituents of underarm cosmetics might play a role in the rising 
Figure 2. Diagrammatic representation of how estrogen disrupting chemicals may influence metastasis of breast cancer cells. Through 
their estrogenic activity, they may increase growth of cells at the primary site in the breast or at metastatic sites. They may enable 
EMT, increase cell migration and cell invasion. Through their widespread presence in the human body, they may provide a favourable 
microenvironment for colonization and metastatic tumour growth
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incidence of breast cancer if sufficient of the constituent chemicals were absorbed either from long-term 
exposure on the skin (these products are not washed off) or from damaging the skin by shaving prior to 
cosmetic application[82,83]. This was proposed partly due to the disproportionately high incidence of breast 
cancer in the upper outer quadrant of the breast which is coincidentally also the site of application of 
these chemicals. Many years on, it is now known that many of the constituent chemicals can be absorbed 
through even intact skin after a single application[84,85] and that they are measurable in human breast tissue 
or human milk (see above for references). Published studies have linked the levels of some of these estrogen 
disrupting chemicals in the body tissues with personal care product usage[86,87]. However, it is also clear 
that these chemicals are getting into many body tissues other than breast and therefore could be expected 
to create distant estrogenic microenvironments which could influence not only the growth of the primary 
tumour but also growth of metastatic tumours. If excessive use of personal care products is involved in 
the development of metastatic breast cancer, then reduction or cessation in use could provide a prevention 
strategy.
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